Topic: Featured

Southern California Regional Cytogenetics & Molecular Genetics Meeting Proves to be Big Success

The Southern California Regional Cytogenetics & Molecular Genetics Meeting last week was a big success. Some of the biggest names in the space attended and were able to provide feedback on the unique cases that were presented, what tools seem to work best, and how they would approach the issue.

The Secret is out - NxClinical 4.1 is here!

We are excited to announce the release of NxClinical 4.1! Our unique software solution for integration of copy number, sequence variants, and allelic changes obtained from microarray and NGS technologies. NxClinical 4.1 allows combined analysis and interpretation of all genomic variants on a single, platform agnostic system.

Looking back at ACMG 2018

The Annual Clinical Genetics Meeting (ACMG) is soon, we wanted to make sure you didn't miss out on the action down in Charlotte, North Carolina! Visit booth #806 or our exhibit theater with Dr. Sarah Murray, UCSD to learn more about CNV, AOH and Sequence Variants Detected from a Single NGS Assay.

ACMG 2018 in Charlotte is Right Around the Corner! 

The Annual Clinical Genetics Meeting (ACMG) is soon, we wanted to make sure you didn't miss out on the action down in Charlotte, North Carolina! Visit booth #806 or our exhibit theater with Dr. Sarah Murray, UCSD to learn more about CNV, AOH and Sequence Variants Detected from a Single NGS Assay.

Paper Review: Detection of copy number alterations in cell-free tumor DNA from plasma

Liquid Biopsy, the detection of circulating tumor DNA in peripheral blood, has been a hot topic in cancer and will keep its momentum in the foreseeable future.

How are systematic correction files used for correcting probe values?

A while back we discussed what systematic correction is and how the files are created to apply this to your data. As a follow up, today we'll explain how the content of systematic correction files are used.

Welcome back to everyone who visited us at AMP 2017

We showed the benefits of an integrated review of CNV, AOH, and SNV using our NxClinical software which handles both array and NGS data in a single system.

Back from China with a Partnership with Be Creative

BioDiscovery inked a deal with Be Creative Lab (Beijing) Co. Ltd. where Be Creative will be the sole reseller and distributor of BioDiscovery products in China. Be Creative is a clinical genetic testing center in Beijing, China, providing diagnostic support for a number of hospitals. Be Creative debuted NxClinical 4.0 at the Clinical Applications Conference which focused on comprehensive application of SNP-Array, NGS and other technology platforms to enhance clinical diagnostics. The conference, hosted by Be Creative, brought together 200 clinical genetics experts.

Cancer statistics in males and females

The US cancer statistics for 2017 were published early this year. Cancer statistics comparison between males and females seems to be the most interesting one.

As NFL season starts, BioDiscovery kicks off with upcoming new software releases

BioDiscovery is starting its new season with new product releases at ASHG in mid-October. It is bound to bring excitement to the genetic testing field, as NFL does to the football fans. Since NGS (next-generation sequencing) is still a hot topic, people will see lots of new things on this front in BioDiscovery's NxClinical 4.0 version.